An Involuntary User Fee: Two Ideas for Off-Label Promotion Fines
This article was originally published in RPM Report
Executive Summary
What if off-label promotion fines were put to good use? A consumer representative and a Senator have thrown out ideas for how to use them.
You may also be interested in...
Medicare/Medicaid Prosecutions: Does More Money for Fraud Activities Translate Into More Mega-Settlements?
From expanding health care coverage to collecting fees from miscreants, the lead story at HHS took a quick and sharp turn with the unveiling of the President's budget for fiscal 2011. HHS is setting high return standards for its fraud activities: $1.5 in net returns to the government for every dollar spent. Practically, that may drive HHS to press big pharma for big settlements.
House ALS Bill Would Require US FDA ‘Action Plan’ – But Not Conditional Approval
US House of Representatives if moving forward with a bill to respond to advocacy from ALS patients for more attention from FDA. The bill focuses on planning and scientific support, not new pathways.
Providers Still See Drawbacks To Opioid Education Mandates
Participants in a US FDA meeting on opioid REMS did not treat a move to mandatory education as a foregone conclusion. Instead, they delved frequently into alternate approaches to enhance the education itself.